Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
Attention Deficit Disorder with Hyperactivity (Phase 1)
Trials (1 total)
Trial APIs (1 total)